A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Morpho Sys Ag stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 123,310 shares of MOR stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
123,310
Previous 124,545 0.99%
Holding current value
$0
Previous $2.27 Million 100.0%
% of portfolio
0.0%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$0.0 - $18.96 $0 - $23,415
-1,235 Reduced 0.99%
123,310 $0
Q2 2024

Jul 19, 2024

BUY
$17.36 - $19.34 $132,699 - $147,834
7,644 Added 6.54%
124,545 $2.27 Million
Q1 2024

Apr 17, 2024

BUY
$8.6 - $18.18 $418,906 - $885,547
48,710 Added 71.43%
116,901 $2.12 Million
Q4 2023

Jan 10, 2024

BUY
$4.55 - $9.9 $310,269 - $675,090
68,191 New
68,191 $675,000

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Hennion & Walsh Asset Management, Inc. Portfolio

Follow Hennion & Walsh Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.